Zinc Patents (Class 514/494)
-
Publication number: 20130028986Abstract: A composition comprising a pharmaceutically acceptable group (2, 4, 12, 13 or 14) metal compound for the treatment of a dermatological condition involving an abnormal decrease in the cell-to-cell adhesion between epithelial cells in the epidermal barrier.Type: ApplicationFiled: August 7, 2012Publication date: January 31, 2013Applicant: SABAREP LIMITEDInventors: Simon Ward, Alice MacGowan, Michael J. Cork, Jonathan Hadgraft, Majella Lane, Adrian Davis, Richard Guy
-
Patent number: 8362051Abstract: Wallboard and facing paper that provides increased mold resistance at lower biocide loadings. The biocide is: (a) an n-alkyl isothiazolinone such as octylisothiazolinone (OIT), a monohalo and dihalo substituted n-alkylisothiazolinone such as chloromethylisothiazolinone (CMIT) or dichlorooctylisothiazolinone (DCOIT), 3-iodo-2-propynyl-butylcarbamate (IPBC), chlorothalonil, methylene-bis-thiocyanate, or mixtures of two or more thereof; or (b) carbendazim and a second biocide selected from 3-iodo-2-propynyl-butylcarbamate (IPBC), diiodomethyltolylsulfone (DIMTS), sodium pyrithione, octylisothiazolinone (OIT), dichlorooctylisothiazolinone (DCOIT), and chlorothalonil.Type: GrantFiled: January 18, 2008Date of Patent: January 29, 2013Assignee: Rohm and Haas CompanyInventors: Sheila M. Tinetti, Paul Foley, Li Wang, Michael V. Enzien, Sanjay B. Bishnoi
-
Publication number: 20130012556Abstract: Bioactive agrichemical concentrates and compositions having improved bioactivity comprising combinations of acid solutions and conventional bioactive agrichemical actives or formulations.Type: ApplicationFiled: September 14, 2012Publication date: January 10, 2013Applicant: SCIESSENT LLCInventor: Joseph J. Crudden
-
Publication number: 20130004587Abstract: Bioactive agrichemical concentrates and compositions having improved bioactivity comprising combinations of acid solutions and conventional bioactive agrichemical actives or formulations.Type: ApplicationFiled: September 14, 2012Publication date: January 3, 2013Applicant: SCIESSENT LLCInventor: Joseph J. Crudden
-
Publication number: 20120315223Abstract: Compositions containing polymetal complexes useful in treating disorders of the oral mucosa, lips, and perioral regions are described.Type: ApplicationFiled: June 13, 2011Publication date: December 13, 2012Inventor: José E. Ramirez
-
Patent number: 8318803Abstract: The present invention relates to an EC SOD and the use thereof. More particularly, the present invention relates to an EC SOD and the use thereof for preventing or treating skin diseases, particularly dermatitis or psoriasis.Type: GrantFiled: April 22, 2010Date of Patent: November 27, 2012Assignees: Bio Clue & Solution Co., Ltd.Inventors: Tae-Yoon Kim, Bo-Yeun Choung
-
Patent number: 8317912Abstract: The present invention relates to an antimicrobial composition comprising an isothiazolin-3-one, such as 1,2-benzisothiazolin-3-one, a zinc compound selected from zinc salts, zinc oxide, zinc hydroxide or combinations thereof, a pyrithione salt or pyrithione acid, and a surfactant selected from the group consisting of (i) an anionic surfactant having a sulfate or sulfonate moiety attached to a straight or branched chain containing from about 10 to about 18 atoms at the backbone of the chain, (ii) an anionic surfactant being an alkylaryl sulfonic acid or salt thereof wherein the alkyl portion contains from about 10 to about 18 carbon atoms, and the aryl portion contains a benzyl or substituted benzyl group, and combinations thereof. This composition is particularly effective in preventing the growth of various microorganisms in mineral slurries such as aqueous calcium carbonate slurries.Type: GrantFiled: March 9, 2012Date of Patent: November 27, 2012Assignee: Arch Chemicals, Inc.Inventors: Helen Margaret Hyde, Fitzgerald Clarke, Helmut Peters, Terri Williams
-
Publication number: 20120294911Abstract: Topical sanitizer includes avenanthramides, which is an active component of oats that is beneficial to the skin. The topical sanitizer is used preferably in conjunction with gloves that have an inner coating that includes avenanthramides. By using topical sanitizer that includes avenanthramides before and after wearing gloves, the skin of the person wearing the glove is more exposed to the beneficial avenanthramides all during the workday, not just when wearing gloves. The result is healthier, much softer and more comfortable skin on the hands.Type: ApplicationFiled: May 27, 2011Publication date: November 22, 2012Applicant: DERMA CARE PLUS PRODUCTS, LLCInventors: Mark James Redmond, Joseph H. Neuser
-
Patent number: 8313767Abstract: Sustained release microparticles suitable for various types of drugs, or drug-containing sustained release microparticles capable of sustained release of drugs over a period of three days or more and capable of inhibiting initial burst release; a process for producing the same; and preparations containing the microparticles are disclosed. The drug-containing sustained release microparticles comprise a drug other than human growth hormone and a porous apatite derivative, and optionally include a water-soluble bivalent metal compound.Type: GrantFiled: September 2, 2010Date of Patent: November 20, 2012Assignee: Independent Administrative Institution, National Institute for Materials ScienceInventors: Yutaka Mizushima, Yasuaki Ogawa, Junzo Tanaka, Toshiyuki Ikoma
-
Publication number: 20120276214Abstract: Provided is an infant nutrition comprising at least one protease inhibitor, a process for preparing such an infant nutrition and use of the infant nutrition for the treatment and/or prevention of childhood obesity and secondary disorders resulting from childhood obesity.Type: ApplicationFiled: May 1, 2012Publication date: November 1, 2012Inventors: Katrien Maria Jozefa VAN LAERE, Bernardina Johanna Martina DELSING, Christopher BEERMANN, Rene John RAGGERS
-
Publication number: 20120277306Abstract: Provided is a method for treating prostate and/or testicular disease, comprising: administering a pharmaceutical composition comprising a zinc-aspartate chelate as an active ingredient to a subject in need thereof, wherein the prostate disease is selected from the group consisting of prostatitis, enlargement of prostate and prostate cancer. The composition for accelerating absorption of metals, comprising a metal-acidic amino acid chelate as an active ingredient. The composition of the present invention has therapeutic effects on prevention and treatment of various diseases arising from a deficiency or shortage of metals, by utilization of a metal-acidic amino acid chelate that exhibits excellent effects of improving delivery and absorption of a drug into target organs, such that pharmaceutical effects of individual metals can be exerted.Type: ApplicationFiled: July 6, 2012Publication date: November 1, 2012Inventor: Myunggyu PARK
-
Patent number: 8299285Abstract: A metal complex of formula (III) wherein: M is a transition metal and A1, A2, X, X?, Y, L1?, R1? and R2? are as defined herein, is useful in medical imaging and therapy.Type: GrantFiled: July 5, 2006Date of Patent: October 30, 2012Assignee: Isis Innovation LimitedInventors: Jonathan Robin Dilworth, Josephine Mary Peach, Julia May Heslop, Paul Stephen Donnelly
-
Publication number: 20120270850Abstract: The present invention relates to metal complexes, processes for their preparation and their use as pharmaceutical or veterinary agents, in particular for the treatment of conditions in which metal delivery can prevent, alleviate or ameliorate the condition. There are a number of clinical conditions which are caused by or associated with abnormal levels of metals (typically low metal levels). Conditions in of this type include cancer and conditions characterised by or associated with oxidative damage, more specifically neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease or Huntington's disease. The invention also relates to ligands useful in the preparation of metal complexes of this type.Type: ApplicationFiled: November 20, 2007Publication date: October 25, 2012Applicant: UNIVERSITY OF MEDLBOURNEInventors: Kevin Jeffrey Barnham, Paul Stephen Donnelly, Anthony Robert White
-
Patent number: 8288426Abstract: A composition comprising fenamidone (a) and an insecticide compound (b) in a (a)/(b) weight ratio of from 1/1000 to 1000/1. A composition further comprising an additional fungicidal compound. A method for preventively or curatively combating the pests and diseases of crops by using this composition.Type: GrantFiled: December 21, 2007Date of Patent: October 16, 2012Assignee: Bayer CropScience AGInventors: Heike Hungenberg, Wolfgang Thielert, Koen Van Den Eynde
-
Patent number: 8287893Abstract: Bioactive agrichemical concentrates and compositions having improved bioactivity comprising combinations of acid solutions and conventional bioactive agrichemical actives or formulations.Type: GrantFiled: May 19, 2008Date of Patent: October 16, 2012Assignee: Sciessent LLCInventor: Joseph J. Crudden
-
Patent number: 8282951Abstract: Antimicrobial coatings to protect surfaces and a method of applying such a coating are disclosed. An antimicrobial coating may be applied to a surface, such as the interior surface of a building's exterior wall. The interior surface must be accessed, and then an antimicrobial coating is provided and applied. The antimicrobial coating includes an inorganic antimicrobial additive and a colloidal polymeric medium. The inorganic antimicrobial additive may be silver, platinum, gold, palladium, copper, zinc, boron, or a compound of any of those elements. By including an ultraviolet tracer or color dye additive in the coating, it is possible to detect the coating at any time, provided that the surface is accessed.Type: GrantFiled: January 4, 2010Date of Patent: October 9, 2012Assignee: EnviroCare CorporationInventor: Bryan M. Redler
-
Publication number: 20120251464Abstract: Compounds are described that are effective in enhancing the efficacy of antimicrobial agents. Also described are methods of using such compounds and compositions that include such compounds. The composition includes a chalcone compound and, optionally, an antimicrobial agent.Type: ApplicationFiled: December 18, 2009Publication date: October 4, 2012Applicants: Indian Institute of Integrative Medicine, Colgate-Palmolive ComplanyInventors: Ravi Subramanyam, Laurence Du-Thumm, Ghulam Nabi Qazi, Inshad Ali Khan, Krishan Avtar Suri, Naresh Kumar Satti, Furqan Ali, Nitin Pal Kalia
-
Publication number: 20120245080Abstract: The present disclosure generally relates to the medical use of compositions comprising a mineral salt and a sulfonic acid for prevention and/or treatment of one or more mucosal diseases, disorders, or conditions or one or more dermal diseases, disorders, or conditions.Type: ApplicationFiled: April 15, 2010Publication date: September 27, 2012Applicant: BMG PHARMA LLCInventors: William A. Goolsbee, Jeffrey L. Lillard
-
Patent number: 8273791Abstract: Compositions, kits and regimens for treatment of damaged skin, especially décolletage, include application of a retinoid, hydroquinone or hydroquinone derivatives, and a composition containing a multi-metal complex.Type: GrantFiled: December 10, 2008Date of Patent: September 25, 2012Assignee: JR Chem, LLCInventors: José E. Ramirez, Joseph R. Faryniarz
-
Publication number: 20120238521Abstract: The invention is directed to a composition and associated method for the treatment of musculoskeletal related disorders and diseases. In particular, the present invention provides a class of citrate compounds that can be used to for the treatment of diseases/disorders characterized by the degeneration of musculoskeletal tissues including menisci, bone, articular cartilage, and soft tissues. Examples of suitable citrate and citrate analog compounds include citrates having the following base formula (I): where X may be one of the following: wherein Y, Y?, and Y? are independently a citrate moiety, O, O—Y, OH, NH, NH—Y, R and R—Y, with R being an alkyl, alkyene, ester, aryl, or phenyl group having from 1 to 6 carbon atoms.Type: ApplicationFiled: March 12, 2012Publication date: September 20, 2012Applicant: The Charlotte-Mecklenbury Hospital Authority d/b/a Carolinas Medical CenterInventors: Yubo Sun, Edward N. Hanley
-
Patent number: 8268790Abstract: Aqueous preparations of substantially equimolor amounts of a zinc salt and clindamycin phosphate form a polymer useful in the topical treatment of acne and rosacea, with very low systemic levels of clindamycin.Type: GrantFiled: October 6, 2009Date of Patent: September 18, 2012Assignee: Zindaclin LimitedInventors: Emma Louise McDonagh, Rebecca Louise Kanis
-
Patent number: 8268363Abstract: The invention relates to the application of a combination including all forms of zinc or zinc substances, at least one of an orally applied combination of a free thiol group or a group that is metabolized to a free thiol in a mammal, and as the only pure plant part, glycyrrhicinic acid or the substance from succus liquiritiae, for the production of a medication to fight acute or chronic viral infections. The free thiol group or the group that is metabolized to a free thiol in a mammal is derived from N-acetylcysteine, methionine, cysteine, allylcysteine, alpha lipoic acid, or sulfur.Type: GrantFiled: September 3, 2004Date of Patent: September 18, 2012Inventor: Dana Flavin-Koenig
-
Patent number: 8258180Abstract: Organic zinc salts and mixtures thereof, organic zinc salt coated particles, methods of preparing organic zinc salts and organic zinc salt coated particles, and various applications of such coated particles, including applications in rubber, other polymeric materials, and pesticides and/or fungicides are disclosed.Type: GrantFiled: December 30, 2008Date of Patent: September 4, 2012Inventor: Raymond L. Nip
-
Publication number: 20120219610Abstract: Antimicrobial bar compositions can include, for example, from about 0.1% to about 35%, by weight of the antimicrobial bar composition, of water; from about 45% to about 99%, by weight of the antimicrobial bar composition, of soap; and from about 0.01% to about 5%, by weight of the antimicrobial bar composition, of platelet zinc pyrithione (“platelet ZPT”). The platelet ZPT includes a median particle diameter of about 2 microns to about 3 microns, a mean particle diameter of about 3 microns to about 4 microns, and a thickness of about 0.6 microns to about 15 microns.Type: ApplicationFiled: February 28, 2011Publication date: August 30, 2012Inventors: Edward Dewey Smith, III, Jason Edward Cook, Brian Joseph Limberg
-
Publication number: 20120220651Abstract: The present invention relates to methods kits and combined compositions using DFO-metal complexes, specifically, Zinc-desferrioxamine (Zn-DFO), gallium-desferrioxamine (Ga-DFO) complexes and any combinations thereof for preventing, treating, ameliorating or inhibiting an immune-related disorder, specifically, a skin-related inflammatory disorder such as psoriasis, an inflammatory respiratory condition such as asthma, and an autoimmune disease such as diabetes and any immune-related disorder.Type: ApplicationFiled: August 19, 2010Publication date: August 30, 2012Applicants: Hadasit Medical Research Services & Development Lt, Yissum Research Development Company of the HebrewInventors: Mordechai Chevion, Vladimir Vinokur, Eduard Berenshtein, Ron Eliashar, Baruch Bulvik
-
Patent number: 8247435Abstract: The present disclosure provides for a scientific formulation useful in the treatment and prevention of human and animal diseases. A biologically effective amount of each of the components of the formulation is administered to patients in pill (or capsule) form via multiple different and identifiable pills. The compounds of the formulation are segregated into different pill types, and contain various amounts of the compounds Curcumin, Genistein, Squalamine, Vitamin E, N-Acetyl-Cysteine, Methylselenocysteine, Zinc Gluconate, B Complex, Lentinen, Coenzyme Q10 Acetyl-L-Carnitine, Lipoic Acid, Resveratrol, and Vitamin C. Furthermore, Arabinoxylan and/or Peperine may be added to the various pill formulations.Type: GrantFiled: February 19, 2009Date of Patent: August 21, 2012Inventor: Jerry T. Thornthwaite
-
Publication number: 20120189569Abstract: This invention relates to complexes of certain divalent and polyvalent d-orbital metals of first transition series of the Periodic Table of Elements, from Group IV to Group VI, and including molybdenum, having a hydroxy acid [HA] and an amino acid [AA] moiety concurrently bound to a single said metal and having a spirocyclic, bidentate chelate structure of formula (I). Upon topical application said metal complexes undergo enhanced skin penetration without causing skin irritation.Type: ApplicationFiled: April 5, 2012Publication date: July 26, 2012Applicant: BIODERM RESEARCHInventor: SHYAM K. GUPTA
-
Publication number: 20120177583Abstract: Compositions containing polymetal complexes are useful in treating anorectal disorders.Type: ApplicationFiled: June 16, 2011Publication date: July 12, 2012Inventor: José E. Ramirez
-
Publication number: 20120177582Abstract: Compositions containing polymetal complexes useful in treating anorectal disorders.Type: ApplicationFiled: January 11, 2011Publication date: July 12, 2012Inventor: José E. Ramirez
-
Publication number: 20120177720Abstract: A wound dressing includes one or more layers containing a first anti-microbial agent and optionally at least one of: a chelating agent, a second anti-microbial agent, a zinc-containing agent, a cell-signaling agent, and an additional active ingredient or agent.Type: ApplicationFiled: March 21, 2012Publication date: July 12, 2012Applicant: Tyco Healthcare Group LPInventors: Harish A. Patel, Hansen P. Swaniker, David G. Heagle, Kate Ward, Alain Tranchemotagne
-
Patent number: 8216971Abstract: The present invention relates to a pesticide composition intended for protecting plants, crops or seeds against phyto-pathogenic fungi or damaging insects, and the corresponding methods of treatment using the said composition. More precisely, the subject of the present invention is a pesticide composition based on propamocarb-HCl, an insecticide active substance and optionally a further fungicide active substance.Type: GrantFiled: December 21, 2007Date of Patent: July 10, 2012Assignee: Bayer Intellectual Property GmbHInventors: Koen van Den Eynde, Wolfgang Thielert, Heike Hungenberg
-
Patent number: 8211873Abstract: This invention relates to certain chirally-correct mitoprotectant phosphorylated heterocyclic agents [formula (I)], which are useful for the treatment of dermatological disorders that include challenged skin from cancer, diabetes, radiation treatments, chemotherapy, and sun-burn; mitochondrial dysfunction; age spots; acne, loss of cellular antioxidants; skin changes associated with aging including collagen loss, loss of skin pliability, loss of skin suppleness, skin wrinkles and fine lines, oxidation, damage from radiation, damage from free radicals, and damage from UV; dry skin; xerosis; ichthyosis; dandruff; brownish spots; keratoses; melasma; lentigines; liver spots; skin pigmentation including pigmented spots, dark circles under the eyes, darkened skin, and blemishes; oily skin; warts; eczema; pruritic skin; psoriasis; inflammatory dermatoses; topical inflammation; disturbed keratinization; scalp dryness; skin depigmentation, and combinations thereof;Type: GrantFiled: August 6, 2010Date of Patent: July 3, 2012Assignee: Island Kinetics, inc.Inventors: Shyam K Gupta, Linda Walker
-
Patent number: 8198321Abstract: The invention relates to a terpenic composition for use as an anti-micro-organism or anti-viral agent comprising a cyclic terpenic compound obtained from a terpene of the general formula (C5H8)n, n being in the range of 2 to 5; and to a vector-forming organic substance, associated to the said cyclic terpenic compound.Type: GrantFiled: November 16, 2007Date of Patent: June 12, 2012Inventor: Aurèle Henri Mannarini
-
Patent number: 8187638Abstract: Here we disclose the response of normal human cells to ZnO nanoparticles under different signaling environments and compare it to the response of cancerous cells. ZnO nanoparticles exhibit a strong preferential ability to kill cancerous T cells (˜28-35X) compared to normal cells. Interestingly, the activation state of the cell contributes toward nanoparticle toxicity as resting T cells display a relative resistance while cells stimulated through the T cell receptor and CD28 costimulatory pathway show greater toxicity in direct relation to the level of activation. The novel findings of cell selective toxicity towards potential disease causing cells indicate a potential utility of ZnO nanoparticle in the treatment of cancer and/or autoimmunity.Type: GrantFiled: September 22, 2008Date of Patent: May 29, 2012Assignee: Boise State UniversityInventors: Alex Punnoose, Madhusudan R. Kongara, Denise Wingett
-
Patent number: 8178498Abstract: A medicinal composition includes an active medicinal substance in therapeutic dose and a potentiated medicinal preparation produced from the substance by homeopathis methods.Type: GrantFiled: February 10, 1997Date of Patent: May 15, 2012Inventor: Oleg Iliich Ephstein
-
Publication number: 20120101155Abstract: The present invention provides for compositions and methods that may offer protection from irritants as well as antimicrobial protection. Preferred embodiments of the invention include topical antimicrobial compositions that lack conventional antibiotics or preservatives, wherein the antimicrobial benefit is created by essential oils (or their active ingredients), emollient solvents and, in some instances, anti-inflammatory agents.Type: ApplicationFiled: January 4, 2012Publication date: April 26, 2012Inventors: Shanta M. Modak, Trupti Gaonkar, Milind Shintre
-
Publication number: 20120093898Abstract: A composition containing a plurality of water-soluble nanoclusters ranging from 2 nm to 500 nm in diameter. Each of the nanoclusters contains one or more metal cations, one or more anions, and one or more water-soluble ligands. Also disclosed is a method of using the composition for treating various disorders such as anemia, heartburn, and diabetes.Type: ApplicationFiled: November 18, 2010Publication date: April 19, 2012Applicant: LG Bionano, LLCInventor: Chien-Chin Wu
-
Patent number: 8148563Abstract: Bimetal chelates are prepared from a solution formed by adding to a solvent one or more polyfunctional acids with basic salts of two or more coordination elements listed in Groups IIIA to VIIIA, Groups IB to IIIB, of periods 4 and 5 and aluminum in Group IIIB, period 3 of The Periodic Table of the Elements and recovering the chelate. Such chelates can be used to formulate useful products.Type: GrantFiled: February 19, 2010Date of Patent: April 3, 2012Assignee: JR Chem, LLCInventors: Jose E. Ramirez, Joseph Faryniarz
-
Publication number: 20120071552Abstract: A method of providing zinc to a subject in need of treatment includes administering to the subject an effective amount of a zinc-cysteine complex. The zinc-cysteine complex is preferably a zinc-monocysteine complex. The complexes of zinc-cysteine of the present invention increase the activity of antioxidant enzymes catalase and glutathione peroxidase, and the antioxidant protein metallothionein. The complexes of zinc-cysteine of the present invention protect retinal pigment epithelial cells from increasing hydrogen peroxide concentrations.Type: ApplicationFiled: November 29, 2011Publication date: March 22, 2012Inventors: David A. Newsome, David Tate
-
Patent number: 8137659Abstract: A composition comprises a non-ionic surfactant and hydrophobic particles of metal oxide having the mean length of the primary particles in the range from 50 to 90 nm, the mean width of the primary particles in the range from 5 to 20 nm, and the median volume particle diameter of the secondary particles is less than 45 nm. The composition is particularly suitable for use in aqueous media, and can be used in a sunscreen product that exhibits both effective UV protection and improved transparency.Type: GrantFiled: November 13, 2002Date of Patent: March 20, 2012Assignee: Croda International PLCInventor: Loma Margaret Kessell
-
Publication number: 20120060258Abstract: A composition for coating a polypropylene-based fabric or polypropylene-based material for use in decreasing the transmission of human pathogens. A device such as a protective face mask made from a polypropylene-based fabric or polypropylene-based material coated with the composition.Type: ApplicationFiled: May 21, 2010Publication date: March 15, 2012Inventors: Neal G. Stewart, Francis Chi Nan Lau, Tai Wai Kung, Lok Yuen Lo, Dacey J. Ryan, Reid W. Von Borstel
-
Publication number: 20120058075Abstract: A method of killing and removing bacteria, mold, mildew or fungus from a surface or keratin substrate includes contacting the surface with an aqueous solution containing a multi carboxylic alpha hydroxy acid, a mono carboxylic organic acid and optionally Aloe. The aqueous solution has a pH of less than 2. The method can also be used to deodorize fabrics, surfaces or stagnant water. The method can also be used to treat wounds and skin irritations.Type: ApplicationFiled: March 3, 2011Publication date: March 8, 2012Inventors: Michael Anthony Petrucci, Thomas B. Kelley
-
Publication number: 20120058199Abstract: The present invention provides the use of surface active proteins, especially class I and class II hydrophobins, in topically applied pharmaceutical formulations. The invention is particularly directed to topically applied pharmaceutical products for enhancing the penetration to achieve a transungual delivery of a prophylactically and/or therapeutically effective amount of an active ingredient (drug) to a patient (including animals and humans) into and/or through a nail, of the animal or human body, in order to treat one or more of a variety of diseases or disorders. Related embodiments of the invention are also disclosed.Type: ApplicationFiled: February 19, 2010Publication date: March 8, 2012Applicant: BASF SEInventors: Andreas Buthe, Andreas Hafner, Franz Kaufmann, Babette Fiedler, Guido Meurer, Gordon Bradley
-
Patent number: 8119167Abstract: Use of a composition comprising cartilage or chondroitin sulphate and absorbable zinc for the preparation of a food supplement or a drug suitable for promoting iron absorption in patients suffering from lack of iron.Type: GrantFiled: February 20, 2008Date of Patent: February 21, 2012Assignee: Medestea Research & Production S.R.L.Inventor: Gianfranco Merizzi
-
Publication number: 20120039820Abstract: A composition such as an oral care composition comprising an antibacterial system comprising 4-isopropyl-3-methyl phenol (IPMP), a source of zinc ions and an anionic surface active agent is described.Type: ApplicationFiled: April 1, 2010Publication date: February 16, 2012Applicant: Glaxo Group LimitedInventors: Alison Axe, David Bradshaw
-
Publication number: 20120034312Abstract: This invention relates to the use of 4-isopropyl-3-methylphenol (IPMP) for combating inflammation and compositions comprising IPMP for such use.Type: ApplicationFiled: April 1, 2010Publication date: February 9, 2012Inventor: Jingjun Yang
-
Publication number: 20120009274Abstract: The present invention relates to the use of hydrazone compounds and copper for controlling the growth of fungi.Type: ApplicationFiled: January 14, 2010Publication date: January 12, 2012Applicant: Dow Agrosciences LLCInventors: David H. Young, Steven Howard Shaber, Cruz Avila-Adame, Nneka T. Breaux, James M. Ruiz, Thomas L. Siddall, Jeffery D. Webster
-
Publication number: 20120009276Abstract: This invention is based on the observed oxidative stress and increased risk on cardiovascular diseases in subjects with increased lipid peroxidation, in particular with women using oral contraceptives and in hormone replacement therapies. The invention provides compositions and combinations, particularly useful in preventing and or reducing the increased lipid peroxidation in subjects in need thereof. These compositions are based on the synergistic combination of zinc and/or a hydroxyl radical scavenger in reducing lipid peroxidation.Type: ApplicationFiled: August 6, 2010Publication date: January 12, 2012Applicant: PROBIOX SAInventor: Donat Eugene H. De Groote
-
Publication number: 20120003198Abstract: The invention relates to the improvement of visual performance, particularly of visual performance in the darkness, by administration of a colorant that is capable of being incorporated into eye tissue and/or causing yellowing of eye tissue, especially carotenoids, such as lutein and zeaxanthin.Type: ApplicationFiled: September 8, 2011Publication date: January 5, 2012Applicant: DSM IP ASSETS B.V.Inventors: Felix Barker, Regina Goralczyk, Wolfgang Schalch
-
Publication number: 20110311602Abstract: Microbial growth inhibiting solutions and methods of employing the microbial growth inhibiting solutions in flushing and coating medical devices are disclosed. In alternative embodiments, the microbial growth inhibiting solutions include combinations of a chelating agent with a C4-C9 carboxylate antimicrobial agent, for example, such as n-octanoic acid. Methods of using these microbial growth inhibiting solutions for coating a medical device and for inhibiting catheter infection are also disclosed.Type: ApplicationFiled: August 31, 2011Publication date: December 22, 2011Applicant: Organic Medical Ventures, L.L.C.Inventors: Stanley L. Mills, Jacqueline L. Mills, Robert D. Maurer, Gary L. Rayburn, Marvin A. Cuchens